← All trials
NCT03469206
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 21, 2018
- Primary completion
- Sep 30, 2021
- Completion date
- Dec 31, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 540
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Changhai HospitalLead sponsor
- Changhai HospitalReponsible party - principal investigator
- National Health and Family Planning Commission, P.R.ChinaCollaborator
- University of AmsterdamCollaborator
- Cardiovascular Chinese Research CenterCollaborator
- University of AmsterdamOverall official - principal investigator
- Changhai HospitalOverall official - principal investigator
- Wu Jieping Medical FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.